These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3798960)

  • 21. Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype.
    Pink JC; Messing EM; Reznikoff CA; Bryan GT; Swaminathan S
    Drug Metab Dispos; 1992; 20(4):559-65. PubMed ID: 1356735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetylator phenotype in Iraqi patients with atopic dermatitis.
    Najim RA; Al-Waiz MM; Al-Razzuqi RA
    Dermatol Online J; 2006 Dec; 12(7):1. PubMed ID: 17459287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Red cell system and selected red cell enzymes in men occupationally exposed to mercury vapours].
    Zabiński Z; Rutowski J; Moszczyński P; Dabrowski Z
    Przegl Lek; 2006; 63 Suppl 7():74-83. PubMed ID: 17784549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria).
    Jeyakumar LH; Arowoshegbe UA; Akinyinka OO; Akinbami FO; Bababunmi EA
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):57-62. PubMed ID: 2384118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microheterogeneity of glucose-6-phosphate dehydrogenase phenotypes.
    el-Hazmi MA
    Med Lab Sci; 1990 Jan; 47(1):26-9. PubMed ID: 2377032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylator phenotype in patients with allergic diseases and its clinical significance.
    Orzechowska-Juzwenko K; Milejski P; Patkowski J; Nittner-Marszalska M; Malolepszy J
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):420-5. PubMed ID: 2258251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.
    Bluhm RE; Adedoyin A; McCarver DG; Branch RA
    Clin Pharmacol Ther; 1999 Jun; 65(6):598-605. PubMed ID: 10391665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylation phenotype and skin complexion.
    Rampen FH; van der Meeren HL; Stolk LM
    Acta Derm Venereol; 1986; 66(4):334-6. PubMed ID: 2430405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylation in healthy and diseased children.
    Hadasová E; Brysová V; Kadlcáková E
    Eur J Clin Pharmacol; 1990; 39(1):43-7. PubMed ID: 2276387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylation of dapsone by human whole blood.
    Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM; Gharaibeh NS
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):18-22. PubMed ID: 8444513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylator phenotype and congenital malformations.
    Stoll C; Roth MP; Dott B; Doumit N; Alembik Y; Welsch M; Imbs JL
    Eur J Clin Pharmacol; 1989; 36(2):151-3. PubMed ID: 2721540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of isoniazid acetylation phenotypes in North Indians.
    Gupta RC; Nair CR; Jindal SK; Malik SK
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):259-64. PubMed ID: 6746149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylator polymorphism in Parkinson's disease.
    Ladero JM; Jimenez FJ; Benitez J; Fernandez-Gundin MJ; Martinez C; Llerena A; Cobaleda J; Muñoz JJ
    Eur J Clin Pharmacol; 1989; 37(4):391-3. PubMed ID: 2598972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylator phenotype and the antihypertensive response to hydralazine.
    Jounela AJ; Pasanen M; Mattila MJ
    Acta Med Scand; 1975 Apr; 197(4):303-6. PubMed ID: 1136859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphic acetylation of sulfamethazine in a Nigerian (Yoruba) population.
    Jeyakumar LH; French MR
    Xenobiotica; 1981 May; 11(5):319-21. PubMed ID: 7293222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of double genetic polymorphism on response to sulfamethazine.
    Woolhouse NM; Atu-Taylor LC
    Clin Pharmacol Ther; 1982 Mar; 31(3):377-83. PubMed ID: 7060320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphic acetylation of sulphamethazine in man: acetylator phenotype in sicklers and non-sicklers.
    Jeyakumar LH; French MR
    Toxicol Lett; 1980 Sep; 6(4-5):263-5. PubMed ID: 7423555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylation phenotype in hypertensive patients.
    Huang CY; Chu JY; Yen TC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Jan; 8(1):1-5. PubMed ID: 1548734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylator polymorphism in rheumatoid arthritis.
    Ladero JM; Andres MP; Bañares A; Fernández B; Hernández C; Benítez J
    Eur J Clin Pharmacol; 1993; 45(3):279-81. PubMed ID: 8276055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.